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Abstract
Objective. The objective of this study was to assess the relationship between active smoking as well as environmental
tobacco smoke (ETS) exposure and severe small for gestational age (SGA) at term in a sample of pregnant Italian women.
Methods. A case–control study was conducted in nine cities in Italy between October 1999 and September 2000. Cases of severe
SGA were singleton, live born, at term children with a birth weight 5th percentile for gestational age. Controls (10:1 to cases)
were enrolled from among singleton at term births that occurred in the same hospitals one or two days after delivery of the case,
with a birth weight4 10th percentile for gestational age. A total of 84 cases of severe SGA and 858 controls were analyzed. A self-
administered questionnaire was used to assess active smoking and ETS exposure, as well as potential confounders.
Results. Multivariate logistic regression analysis showed a relationship between active smoking during pregnancy and severe
SGA (adjusted odds ratio (OR) 2.10, 95% confidence interval (CI) 1.13–3.68). ETS exposure was associated with severe
SGA (adjusted OR 2.51, 95% CI 1.59–3.95) with a dose–response relationship to the number of smokers in the home.
Keywords: Severe small for gestational age at term, active smoking, environmental smoke exposure, Italy, case–control study
Introduction
Low birth weight is an important cause of fetal
mortality as well as neonatal morbidity and mortality
in developed countries [1], and active smoking is the
major modifiable risk factor contributing to limited
birth weight [2].
There is documented and unequivocal epidemio-
logical evidence to support an association between
active smoking during pregnancy and preterm
delivery, premature rupture of the membranes, low
birth weight (LBW), intrauterine growth restriction
(IUGR), small for gestational age (SGA), placenta
previa, abruptio placentae, and sudden infant death
syndrome (SIDS) [3,4].
The general acceptance of the association between
smoking and impairment of fetal growth is illustrated
by numerous studies: maternal smoking retards fetal
growth, causes an average reduction in birth weight
of 165 g [5], and is associated with an increased risk
of SGA (adjusted odds ratio (OR) 2.41, 95%
confidence interval (CI) 1.78–3.28) [6,7].
On the whole, data from several studies show that
there isa dose–response effectof smoking on bothmean
birth weight and the incidence of LBW infants with an
adjusted OR of 2.3 (95% CI 2.0–2.04) for smoking
pregnant women compared to non-smokers [8,9].
Decrements in birth weight have also been
associated with environmental tobacco smoke
(ETS) exposure during pregnancy. A recent meta-
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analysis of 16 studies reported a pooled OR for either
LBW or SGA of 1.22 (95% CI 1.10–1.35) in exposed
versus unexposed pregnant women [10]. Moreover, a
strong dose-effect has been observed: in a recent
study, in mothers heavily exposed to ETS both at
home and at work, infant birth weight was lower by
189 g in comparison with the group of non-exposed,
never smoking mothers and even 70 g compared with
mothers smoking during pregnancy [11].
We studied the association between the occur-
rence of an impairment of fetal growth such as severe
SGA and maternal active smoking and ETS ex-
posure during the last trimester of pregnancy in a
sample of Italian women. The study was conducted
within a larger investigation of several risk factors for
adverse pregnancy outcomes [12].
Methods
A population-based case–control study with incident
cases was carried out between October 1999 and
September 2000 in nine Italian cities (Genoa, Udine,
Modena, Parma, Siena, Rome, L’Aquila, Naples,
and Catania). In Modena, Udine, Parma, Siena, and
L’Aquila, the participating obstetric clinics covered
nearly 100% of the total births that occurred in the
municipal areas, while in Rome, Genoa, Naples, and
Catania the coverage ranged from 40% to 60% of
total births. We considered babies born from
mothers who where Caucasian, born in Italy, and
resident in the investigated cities eligible for inclu-
sion. Multiple pregnancies and newborns with
congenital malformations were excluded.
Eligible cases of babies with an impairment of fetal
growth were singleton, live born, at term children
with a birth weight 5th percentile for gestational
age, considered severe SGA babies. Controls (10:1
to cases) were enrolled from among singleton at term
births that occurred in the same hospitals one or two
days after delivery of the case, with a birth
weight4 10th percentile for gestational age.
Mothers of cases and controls were recruited during
their hospital stay, which lasted 48–72 hours after
delivery, by trained interviewers. Interviewers re-
cruited cases (and controls) 1–2 days/week, excluding
holidays, in a random fashion. After informed consent
and before hospital discharge, mothers were asked to
complete a structured, validated, and self-admini-
strated questionnaire [13]. The questionnaire col-
lected information on maternal socio-demographic
status (mother’s age, educational level, etc.), obstetric
history (parity, previous miscarriages and stillbirth,
gestational hypertension and diabetes, etc.), and life-
style habits such as coffee, beer, and wine consump-
tion. Maternal and infant medical records were
reviewed to obtain clinical data on mother’s health at
delivery and birth outcomes (infant sex, gestational
age, and infant birth weight). Data on gestational age
were obtained from medical records according to the
last menstrual period. We considered the following
variables as confounders: infant gender, maternal age
(years), marital status (‘with’ or ‘without’ a partner),
education, parity, previous LBW, previous preterm
deliveries, miscarriage, stillbirth, antenatal class atten-
dance, urinary tract infections (UTI), gestational
diabetes and hypertension, proteinuria, edema, anemia
and treatment for anemia, wine, beer, and coffee
consumption, working activities in pregnancy, and
moderatephysical activity. Confounding variables were
assessed both by questionnaire and clinical records.
The study protocol was reviewed and approved by
the research ethics boards of all the obstetric clinics.
Exposure assessment
Information on active smoking habits and ETS
exposure was based on maternal self-reporting [13].
We collected information about smoking habits
before pregnancy (yes/no), the number of cigarettes
smoked per day, and the period of smoking habits
before pregnancy. Data on smoking habits during
pregnancy were also collected. We collected infor-
mation about smoking habits during the last trime-
ster of pregnancy (yes/no) as well as the number of
cigarettes smoked per day: all smokers reported that
they had smoked for the entire period of pregnancy.
ETS exposure was grouped into three categories
based on the number of smokers in the home during
the period of pregnancy (none, one, two smokers).
Statistical analyses
Univariate and multivariate regressionprocedureswere
applied to estimate the associations between maternal
smoking and ETS exposure during pregnancy and
severe SGA. We estimated odds ratios (OR) and 95%
confidence intervals (95% CI) using logistic regres-
sion. The regression models were adjusted for the
following confounders: previous LBW, UTI, gesta-
tional hypertension, and treatment for anemia. These
variables were associated with case status (p50.05) in
univariate analyses. Statistical analyses were performed
with SPSS 10.0 for Windows (SPSS 2000) [14].
Results
A total of 84 cases of severe SGA and 858 controls
completed the questionnaire. Overall the participa-
tion rate was 96% of those eligible. The distribution
of maternal socio-demographic status, obstetric
history, and lifestyle habits in pregnancy (including
smoking) among cases and controls was considered.
Mothers of severe SGA infants were more likely
to have a history of previous LBW, UTI, and
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gestational hypertension than mothers of controls.
Moreover, mothers of controls (non-severe SGA
babies) were more likely to undergo treatment for
anemia suggesting a protective role of this therapy
towards the reduction in newborn birth weight
(Table I).
No association was found with infant gender,
maternal age, marital status (‘with’ or ‘without’ a
partner), education (4 or eight years of educa-
tion), parity (multiparous vs. primiparous), previous
preterm deliveries, miscarriage, stillbirth, antenatal
class attendance, gestational diabetes, proteinuria,
edema, anemia, wine, beer, and coffee consumption,
working activities, and moderate physical activity in
pregnancy for severe SGA babies compared with
control subjects (data not shown). Mothers who had
reported active smoking more frequently delivered
severe SGA babies compared with non-smoker
mothers (14.8%/7.6%). Moreover, 13.8% of
mothers who delivered severe SGA babies were
exposed to ETS while 6.0% were not. Beer, wine,
and coffee intake (no/yes) were not associated with
severe SGA babies.
Adjusted ORs and 95% CIs for smoking habits
before and during pregnancy are shown in Table II.
All risk estimates were adjusted for variables asso-
ciated with severe SGA in the univariate analyses
(previous LBW, UTI, gestational hypertension,
treatment for anemia). Multiple regression analysis
showed a strong association between severe SGA and
smoking during pregnancy. A higher adjusted risk
was found for severe SGA babies among mothers
who smoked during pregnancy compared to
non-smokers with evidence of a dose–response
relationship according to the number of cigarettes
smoked daily. Smoking only before pregnancy and
then stopping did not show a significant risk, while
smoking before and during pregnancy showed
increased risk of severe SGA.
A positive trend in OR values according to
exposure to smoke was observed for severe SGA
babies: ETS exposure was associated with a strong
increase in risk for severe SGA when the analysis was
limited to non-smoking women. When we consid-
ered women with both ETS exposure and active
smoking habits, the association between smoke
exposure and severe SGA became more evident
(Table III).
Discussion
Active smoking during pregnancy is strongly asso-
ciated with severe SGA with a dose–response
relationship: the risk doubled when more than ten
cigarettes/day were smoked with respect to non-
smokers. Only smoking before pregnancy was not
associated with the investigated outcome in a
significant way.
In this study ETS exposure in pregnant women
was significantly associated with a higher risk of
severe SGA, and the value was very close to the risk
for active smoking women (OR 1.95 vs. 2.10).
Several epidemiological research studies have
already evaluated the role of socio-economic factors
and behavioral patterns for associations with SGA. In
addition to unhealthy behavior (cigarette smoking,
Table I. Basic characteristics of cases (severe SGA,5th percentile for gestational age) and controls (410th percentile for gestational age).
Variables
410th percentile for
gestational age (N¼858)
5th percentile for
gestational age (N¼ 84) OR (95% CI) p-Value
Previous low birth weight
(only in multiparous women)
3.54 (1.42–8.82) 0.011
No 556 (90.1%) 61 (9.9%)
Yes 18 (72.0%) 7 (28.0%)
Urinary tract infections (UTI) 1.90 (1.02–3.52) 0.061
No 769 (91.7%) 70 (8.3%)
Yes 81 (85.3%) 14 (14.7%)
Gestational hypertension 2.14 (1.07–4.26) 0.047
No 795 (91.6%) 73 (8.4%)
Yes 56 (83.6%) 11 (16.4%)
Treatment for anemia 1.51 (0.95–2.38) 0.098
Yes (iron, folic acid, or both) 459 (92.7%) 36 (7.3%)
No 389 (89.4%) 46 (10.6%)
Active smoking 2.10 (1.27–3.47) 0.005
No 714 (92.4%) 59 (7.6%)
Yes 144 (85.2%) 25 (14.8%)
ETS exposure 2.51 (1.59–3.95) 0.000
No 548 (94.0%) 35 (6.0%)
Yes 306 (86.2%) 49 (13.8%)
SGA, small for gestational age; OR, odds ratio; CI, confidence interval; ETS, environmental tobacco smoke.
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drug use) [8], the most frequently associated factors
are maternal anthropometry, poor nutrition, mater-
nal age, low maternal education, maternal unem-
ployment or heavily working during pregnancy,
and absence or poor quality of prenatal and family
care [15].
In the actual study, maternal age, marital status,
education, moderate physical activity, working, as
well as further socio-economic and behavioral factors
were not found to be associated with severe SGA.
Such discrepancies could possibly be ascribed to the
strict definition of SGA we utilized, i.e., birth weight
5th percentile. The common definition of SGA
as 10th percentile could overdiagnose the condi-
tion. Indeed, SGA is defined according to gestational
age and 5–20% of estimates of gestational age are
incorrect based on last menstrual period recall [16].
In contrast, some variables from obstetric history
and medical records, such as previous LBW, UTIs,
gestational hypertension, and treatment for anemia,
were found to be associated with the outcome and
were adjusted for in the multivariate analysis.
Some methodological limitations, however, should
be considered in interpreting the results of our study.
The first issue is related to the sample: while in some
towns the coverage of preterm births was 100%, in
other areas (Rome, Naples, and Genoa) this was
limited to 40–60% as it was impossible to cover all the
obstetric wards in these big cities. However the sample
from these areas is to be considered homogeneous as
we only involved public hospitals in the present study.
Maternal smoking was based on self-report,
leading to potential misclassification. Although many
studies have shown agreement between the amount
of self-reported smoking and serum or urinary
cotinine levels [17], several issues regarding covari-
ates and confounders need to be addressed. How-
ever, in our study 40.4% of women with severe SGA
and 31% of control women reported that they
smoked before pregnancy. These data agree with
those from the Italian Institute for Statistical
Research [18], who reported that the prevalence of
smoking among Italian women aged 25–44 years was
33.5%, similar to our study and refutes the fact,
suggested by some authors, that mothers may not
report the number of cigarettes smoked in pregnancy
accurately, leading to additional misclassification.
Moreover, in our study a similar reduction in the
prevalence of active smoking was observed both for
controls (715%) and for cases (717%).
The accuracy of the exposure to ETS is difficult to
evaluate when data are collected only by self-
reported questionnaire. The results obtained from
epidemiological studies performed on the validity of
self-reported exposure to ETS are not univocal: a
number of studies have found poor to moderate
correlation between self-reported information on
ETS exposure and cotinine measurements [19–21],
while other studies testing the exposure to ETS and
cotinine levels have shown a good correlation with a
history of this exposure [22,23].
In conclusion, our results add to earlier findings
that active smoking during pregnancy increases the
Table II. Smoking habits of cases (severe SGA, N¼84) and
controls before and during pregnancy.
Cases Controls
Adjusted
OR* (95% CI)
Smoking during pregnancy
No 59 (7.6%) 714 (92.4%) 1.00
Yes 25 (14.8%) 144 (85.2%) 2.10 (1.13–3.68)
p¼0.018
Cigarette/day
during
pregnancy
p¼0.012
None 59 (7.6%) 714 (92.4%) 1.00
510/day 18 (15.1%) 101 (84.9%) 1.82 (0.9–3.56)
p¼ 0.148 (NS)
10/day 7 (14.0%) 43 (86.0%) 2.00 (0.78–5.10)
p¼0.078
Smoking before
and during
pregnancy
p¼0.012
Neither 50 (7.8%) 593 (92.2%) 1.00
Yes, only
before
pregnancy
9 (6.9%) 121 (93.1%) 0.95 (0.43–2.14)
p¼ 0.911 (NS)
Yes, both
before and
during
pregnancy
25 (14.8%) 144 (85.2%) 2.04 (1.13–3.68)
p¼0.018
SGA, small for gestational age; OR, odds ratio; CI, confidence
interval.
*Adjusted for previous low birth weight, urinary tract infections,
gestational hypertension, treatment for anemia.
Table III. ETS exposure of cases (severe SGA, N¼84) and
controls according to the number of smokers in the home and
smoking habits.
Cases Controls
Adjusted
OR*
(95% CI)
Active smoking/
ETS exposure
p¼0.000
No active smoking/
no ETS exposure
30 (5.7%) 499 (94.3%) 1.00
No active smoking/
yes ETS exposure
29 (12.1%) 211 (87.9%) 1.95
(1.05–3.62)
p¼0.035
Yes active smoking/
yes ETS exposure
20 (17.4%) 95 (82.6%) 2.71
(1.41–5.22)
p¼0.003
SGA, small for gestational age; OR, odds ratio; CI, confidence
interval; ETS, environmental tobacco smoke.
*Adjusted for previous low birth weight, urinary tract infections,
gestational hypertension, treatment for anemia.
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risk for SGA in its severe form. However, stopping
smoking before pregnancy reduces this risk.
ETS exposure contributes to the risk of severe
SGA to a similar extent as active smoking, and health
information on this topic must be addressed to
family members of pregnant women.
Declaration of interest: The authors report no
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